A Robust ROS Generation and Ferroptotic Lipid Modulation Nanosystem for Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy
Source abstract
Abstract
Abstract Ferroptosis initiation is often utilized for synergistic immunotherapy. While, current immunotherapy is limited by an immunosuppressive tumor microenvironment (TME), and ferroptosis is limited by insufficient reactive oxygen species (ROS) and ferroptotic lipids in tumor cells. Here, an arachidonic acid (AA) loaded nanosystem (CTFAP) is developed to mutually reinforce ferroptosis and cancer immunotherapy by augmenting ROS generation and modulating ferroptotic lipids. CTFAP is composed of acid‐responsive core calcium peroxide (CaO2) nanoparticles, ferroptotic lipids sponsor AA, tetracarboxylic porphyrin (TCPP) and Fe3+ based metal‐organic framework structure, and biocompatible mPEG‐DSPE for improved stability. Once endocytosed by tumor cells, CTFAP can release oxygen (O2) and hydrogen peroxide (H2O2) in the acidic TME, facilitating TCPP‐based sonodynamic therapy and Fe3+‐mediated Fenton‐like reactions to generate substantial ROS for cell ferroptosis initiation. The immunogenic cell death (ICD) after ferroptosis promotes interferon γ (IFN‐γ) secretion to up‐regulate the expression of long‐chain family member 4 (ACSL4), cooperating with the released AA from CTFAP to accelerate the accumulation of lipid peroxidation (LPO) and thereby promoting ferroptosis in cancer cells.CTFAP with ultrasound treatment efficiently suppresses tumor growth, has great potential to challenges in cancer immunotherapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Ferroptosis and cancer prognosis · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Cancer Center and Institute of Translational Medicine Faculty of Health Sciences University of Macau Macau SAR 999078 China
MoE Frontiers Science Center for Precision Oncology University of Macau Macau SAR 999078 China
Zhejiang Cancer Hospital Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences Hangzhou Zhejiang 310022 China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province · Research Services and Knowledge Transfer Office, University of Macau
References (54)
Show source-provided references
1. 10.3322/caac.2176310.3322/caac.21763 ↗
2. 10.1002/adfm.20200439710.1002/adfm.202004397 ↗
3. 10.1126/science.120348610.1126/science.1203486 ↗
4. 10.1016/j.cell.2023.03.00610.1016/j.cell.2023.03.006 ↗
5. 10.1126/science.abm342510.1126/science.abm3425 ↗
6. 10.1038/s41571-021-00588-910.1038/s41571-021-00588-9 ↗
7. 10.1186/s13045-022-01282-810.1186/s13045-022-01282-8 ↗
8. 10.1038/s41467-023-38245-710.1038/s41467-023-38245-7 ↗
9. 10.1186/s13045-020-00946-710.1186/s13045-020-00946-7 ↗
10. 10.1002/adfm.20211178410.1002/adfm.202111784 ↗
11. 10.1002/adma.20230956210.1002/adma.202309562 ↗
12. 10.1016/j.biomaterials.2023.12230010.1016/j.biomaterials.2023.122300 ↗
13. 10.1021/acsnano.0c0388110.1021/acsnano.0c03881 ↗
14. 10.1021/acsnano.2c0692610.1021/acsnano.2c06926 ↗
15. 10.1021/acsnano.9b0942610.1021/acsnano.9b09426 ↗
16. 10.1038/s41586-019-1170-y10.1038/s41586-019-1170-y ↗
17. 10.1126/science.aaw987210.1126/science.aaw9872 ↗
18. 10.1002/advs.20230295310.1002/advs.202302953 ↗
19. 10.1016/j.biomaterials.2023.12221210.1016/j.biomaterials.2023.122212 ↗
20. 10.1038/s41568-022-00459-010.1038/s41568-022-00459-0 ↗
21. 10.21037/atm-21-694210.21037/atm-21-6942 ↗
22. 10.1186/s13045-019-0720-y10.1186/s13045-019-0720-y ↗
23. 10.1016/j.cell.2022.06.00310.1016/j.cell.2022.06.003 ↗
24. 10.1016/j.cell.2017.09.02110.1016/j.cell.2017.09.021 ↗
25. 10.1002/adma.20220717410.1002/adma.202207174 ↗
26. 10.1002/adma.20230593210.1002/adma.202305932 ↗
27. 10.1016/j.ccr.2023.21502410.1016/j.ccr.2023.215024 ↗
28. 10.1021/acsnano.3c0848510.1021/acsnano.3c08485 ↗
29. 10.1002/smll.20230640210.1002/smll.202306402 ↗
30. 10.1038/nchembio.223910.1038/nchembio.2239 ↗
31. 10.1016/j.ccell.2022.02.00310.1016/j.ccell.2022.02.003 ↗
32. 10.1021/jacs.2c1368910.1021/jacs.2c13689 ↗
33. 10.1021/acsnano.1c0730810.1021/acsnano.1c07308 ↗
34. 10.1016/j.bioactmat.2021.01.02610.1016/j.bioactmat.2021.01.026 ↗
35. 10.1002/adfm.20230325410.1002/adfm.202303254 ↗
36. 10.1021/acsnano.3c0136910.1021/acsnano.3c01369 ↗
37. 10.7150/thno.8785410.7150/thno.87854 ↗
38. 10.1002/anie.20221017410.1002/anie.202210174 ↗
39. 10.1016/j.nantod.2023.10179810.1016/j.nantod.2023.101798 ↗
40. 10.1002/adma.20220628610.1002/adma.202206286 ↗
41. 10.1002/smll.20190211810.1002/smll.201902118 ↗
42. 10.1021/acsami.1c0327710.1021/acsami.1c03277 ↗
43. 10.1038/s41467-021-25990-w10.1038/s41467-021-25990-w ↗
44. 10.1021/jacs.2c0913910.1021/jacs.2c09139 ↗
45. 10.1021/acsnano.2c1287410.1021/acsnano.2c12874 ↗
46. 10.1002/adfm.20220922710.1002/adfm.202209227 ↗
47. 10.1016/j.chempr.2020.02.02010.1016/j.chempr.2020.02.020 ↗
48. 10.1016/j.nantod.2020.10100910.1016/j.nantod.2020.101009 ↗
49. 10.1016/j.bioactmat.2022.09.00610.1016/j.bioactmat.2022.09.006 ↗
50. 10.1021/acsnano.1c0312810.1021/acsnano.1c03128 ↗
51. 10.1073/pnas.141149911110.1073/pnas.1411499111 ↗
52. 10.1021/acsnano.9b0030010.1021/acsnano.9b00300 ↗
53. 10.1002/adma.20160662810.1002/adma.201606628 ↗
54. 10.1038/s41577-019-0210-z10.1038/s41577-019-0210-z ↗